Purchase Order 75F40122P00192
Award Date 8/24/22
Potential Completion Date 7/31/23
Potential Value $439K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' Food and Drug Administration awarded a $749,396.58 firm fixed price purchase order to Pacific Biosciences of California, Inc. to deliver a Versatile Sequencing II System. The sequencing system must be capable of producing long reads between 8,000 to over 20,000 bases, running a minimum of eight multiplexed samples simultaneously, and accommodating a cell confinement structure with 100,000 to 150,000 zero-mode waveguide holes, as specified in the...
- Pacific Biosciences of California, Inc., a small business biotechnology firm specializing in long-read DNA and RNA sequencing technologies, received a $726,318.04 firm fixed-price purchase order from the Food and Drug Administration on September 28, 2023. The award covers a Sequel IIE long-read DNA/RNA sequencer system and associated consumables to support the National Antimicrobial Resistance Monitoring System. The contract, designated as a total small business set-aside, includes performance...
- This is a $505,454 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer of advanced DNA sequencing systems and reagents. The contract is for the delivery of a "REAL TIME DNA SEQUENCER" and is set aside for small business. Pacific Biosciences specializes in their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized by various federal...
- The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a manufacturer of scientific equipment and reagents, for the provision of their Sequel and Sequel II DNA/RNA sequencing systems and associated consumables. The contract has a potential value of $197,441.19 and a completion date of October 12, 2017. Pacific Biosciences has fulfilled over $10 million in federal contracts with...
- The Food and Drug Administration awarded a $47,897.16 delivery order to Pacific Biosciences of California, Inc. on March 30, 2026, for supplies and reagents supporting the PacBio Sequel IIe long-read DNA/RNA sequencer. This delivery order was issued under the FDA's existing Indefinite Delivery Indefinite Quantity (IDIQ) contract 75F40121D00007 with Pacific Biosciences, valued at $1 million and originally extending through March 2025. The work will be performed in Laurel, Maryland, with an...
- This contract award to Pacific Biosciences of California, Inc., a small business manufacturer, is for the provision of high-throughput, long-read DNA sequencing systems and associated consumables to the U.S. Food and Drug Administration (FDA). The $83,644 firm fixed-price purchase order has an ultimate completion date of October 14, 2015. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized...
- The Department of Health and Human Services Food and Drug Administration awarded a $406,184 firm fixed price purchase order contract to Pacific Biosciences of California, Inc. for the provision of DNA sequencer and cluster generator hardware and software, as well as four annual preventative maintenance agreements to be exercised annually. The place of performance will be Laurel, Maryland and the period of performance is from September 26, 2023 through October 26, 2028. The contract was set aside...
- The Department of Health and Human Services Food and Drug Administration awarded a $43,337.06 firm fixed price delivery order to Pacific Biosciences of California, Inc. under the agency's indefinite-delivery/indefinite-quantity contract 75F40121D00007. The delivery order is for the purchase of specific supplies and reagents for use with Pacific Biosciences' PacBio Sequel IIE long-read DNA/RNA sequencer to support the FDA's regulatory science programs. Performance will occur in Laurel, Maryland...
- This is a delivery order awarded to Pacific Biosciences of California, Inc., a manufacturer of DNA/RNA sequencing systems and associated consumables, by the Department of Health and Human Services' Food and Drug Administration. The $69,567.00 firm-fixed-price order is for the provision of sequencing reagents, kits, and consumables to support the agency's genomic research initiatives. Pacific Biosciences has extensive experience providing specialized sequencing equipment and supplies to various...